BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31793787)

  • 1. Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer.
    Gao A; Chen B; Gao J; Zhou F; Saeed M; Hou B; Li Y; Yu H
    Nano Lett; 2020 Jan; 20(1):353-362. PubMed ID: 31793787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy.
    Su Z; Xiao Z; Huang J; Wang Y; An Y; Xiao H; Peng Y; Pang P; Han S; Zhu K; Shuai X
    ACS Appl Mater Interfaces; 2021 Mar; 13(11):12845-12856. PubMed ID: 33709684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.
    Wan Z; Sun J; Xu J; Moharil P; Chen J; Xu J; Zhu J; Li J; Huang Y; Xu P; Ma X; Xie W; Lu B; Li S
    Acta Biomater; 2019 May; 90():300-313. PubMed ID: 30930305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer.
    Hu X; Hou B; Xu Z; Saeed M; Sun F; Gao Z; Lai Y; Zhu T; Zhang F; Zhang W; Yu H
    Adv Sci (Weinh); 2020 Apr; 7(8):1903332. PubMed ID: 32328426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroitin sulfate-based prodrug nanoparticles enhance photodynamic immunotherapy via Golgi apparatus targeting.
    Li H; Deng C; Tan Y; Dong J; Zhao Y; Wang X; Yang X; Luo J; Gao H; Huang Y; Zhang ZR; Gong T
    Acta Biomater; 2022 Jul; 146():357-369. PubMed ID: 35577045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy.
    Wang D; Wang T; Liu J; Yu H; Jiao S; Feng B; Zhou F; Fu Y; Yin Q; Zhang P; Zhang Z; Zhou Z; Li Y
    Nano Lett; 2016 Sep; 16(9):5503-13. PubMed ID: 27525587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROS-Responsive Selenium-Containing Carriers for Coencapsulation of Photosensitizer and Hypoxia-Activated Prodrug and Their Cellular Behaviors.
    Song F; Li S; Sun C; Ji Y; Zhang Y
    Macromol Biosci; 2021 Dec; 21(12):e2100229. PubMed ID: 34390189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.
    Huang Z; Wei G; Zeng Z; Huang Y; Huang L; Shen Y; Sun X; Xu C; Zhao C
    Theranostics; 2019; 9(19):5542-5557. PubMed ID: 31534502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway.
    Yang X; Zhang W; Jiang W; Kumar A; Zhou S; Cao Z; Zhan S; Yang W; Liu R; Teng Y; Xie J
    J Nanobiotechnology; 2021 Jun; 19(1):182. PubMed ID: 34127005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
    Yao D; Wang Y; Bian K; Zhang B; Wang D
    Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
    Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
    ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer.
    Li X; Jeon YH; Kwon N; Park JG; Guo T; Kim HR; Huang JD; Lee DS; Yoon J
    Biomaterials; 2021 Jan; 266():120430. PubMed ID: 33011679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
    Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-responsive prodrug-like PEGylated macrophotosensitizer nanoparticles for enhanced near-infrared imaging-guided photodynamic therapy.
    Ruan Z; Yuan P; Li T; Tian Y; Cheng Q; Yan L
    Eur J Pharm Biopharm; 2019 Feb; 135():25-35. PubMed ID: 30550923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
    Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
    ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia alleviation-triggered enhanced photodynamic therapy in combination with IDO inhibitor for preferable cancer therapy.
    Xing L; Gong JH; Wang Y; Zhu Y; Huang ZJ; Zhao J; Li F; Wang JH; Wen H; Jiang HL
    Biomaterials; 2019 Jun; 206():170-182. PubMed ID: 30939409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy.
    Liu H; Hu Y; Sun Y; Wan C; Zhang Z; Dai X; Lin Z; He Q; Yang Z; Huang P; Xiong Y; Cao J; Chen X; Chen Q; Lovell JF; Xu Z; Jin H; Yang K
    ACS Nano; 2019 Nov; 13(11):12638-12652. PubMed ID: 31625721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.